Jurecka W - Search Results

1

Serum level of VEGF-D in patients with primary lymphedema.

Fink AM, Kaltenegger I, Schneider B, Frühauf J, Jurecka W, Steiner A. Fink AM, et al. Among authors: jurecka w. Lymphology. 2004 Dec;37(4):185-9. Lymphology. 2004. PMID: 15693535

2

Seborrhoeic keratoses in patients with internal malignancies: a case-control study with prospective accrual of patients.

Fink AM, Filz D, Krajnik G, Jurecka W, Ludwig H, Steiner A. Fink AM, et al. Among authors: jurecka w. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1316-9. doi: 10.1111/j.1468-3083.2009.03163.x. Epub 2009 Mar 4. J Eur Acad Dermatol Venereol. 2009. PMID: 19309432

3

Vascular endothelial growth factor in patients with psoriatic arthritis.

Fink AM, Cauza E, Hassfeld W, Dunky A, Bayer PM, Jurecka W, Steiner A. Fink AM, et al. Among authors: jurecka w. Clin Exp Rheumatol. 2007 Mar-Apr;25(2):305-8. Clin Exp Rheumatol. 2007. PMID: 17543159

4

Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.

Fink AM, Holle-Robatsch S, Herzog N, Mirzaei S, Rappersberger K, Lilgenau N, Jurecka W, Steiner A. Fink AM, et al. Among authors: jurecka w. Melanoma Res. 2004 Apr;14(2):141-5. doi: 10.1097/00008390-200404000-00011. Melanoma Res. 2004. PMID: 15057045

5

S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection.

Fink AM, Weihsengruber F, Spangl B, Feichtinger H, Lilgenau N, Rappersberger K, Jurecka W, Steiner A. Fink AM, et al. Among authors: jurecka w. Melanoma Res. 2005 Aug;15(4):267-71. doi: 10.1097/00008390-200508000-00006. Melanoma Res. 2005. PMID: 16034304

6

Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.

Schernthaner GH, Spanblöchl E, Sperr WR, Sillaber C, Semper H, Jurecka W, Hagen W, Wolff K, Chott A, Lechner K, Valent P. Schernthaner GH, et al. Among authors: jurecka w. Ann Hematol. 2000 Dec;79(12):660-6. doi: 10.1007/s002770000206. Ann Hematol. 2000. PMID: 11195002

7

Long-term mortality in patients with thrombosis of the inferior vena cava, iliac and femoral veins.

Fink AM, Herzog N, Borst-Krafek B, Jurecka W, Steiner A. Fink AM, et al. Among authors: jurecka w. Eur J Vasc Endovasc Surg. 2006 Feb;31(2):200-3. doi: 10.1016/j.ejvs.2005.07.013. Epub 2005 Aug 25. Eur J Vasc Endovasc Surg. 2006. PMID: 16125982 Free article.

8

S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.

Fink AM, Lass H, Hartleb H, Jurecka W, Salzer H, Steiner A. Fink AM, et al. Among authors: jurecka w. Ann Surg Oncol. 2008 Mar;15(3):848-53. doi: 10.1245/s10434-007-9694-z. Epub 2007 Nov 28. Ann Surg Oncol. 2008. PMID: 18043975

9

Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.

Fink AM, Wondratsch H, Lass H, Janauer M, Sevelda P, Salzer H, Jurecka W, Ulrich W, Chott A, Steiner A. Fink AM, et al. Among authors: jurecka w. Ann Surg Oncol. 2011 Jun;18(6):1691-7. doi: 10.1245/s10434-010-1545-7. Epub 2011 Jan 20. Ann Surg Oncol. 2011. PMID: 21249455

10

Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.

Feldmann R, Fink AM, Jurecka W, Rappersberger K, Steiner A. Feldmann R, et al. Among authors: jurecka w. Eur J Surg Oncol. 2014 Jan;40(1):73-6. doi: 10.1016/j.ejso.2013.08.022. Epub 2013 Sep 12. Eur J Surg Oncol. 2014. PMID: 24075029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results